Anaesthesia Pain & Intensive Care,
Journal Year:
2023,
Volume and Issue:
27(6), P. 652 - 664
Published: Jan. 12, 2023
Background
&
objective:
Few
studies
have
directly
and
prospectively
compared
ICU
patients
with
acute
respiratory
distress
syndrome
(ARDS)
caused
by
COVID-19
vs.
other
causes.
Almost
all
previously-published
were
retrospective
employed
historical
non-COVID
cases.
We
aimed
to
identify
compare
patient
characteristics
predictors
of
mortality
associated
COVID-related
non-CIVID-related
ARDS.
Methodology:
performed
a
prospective
cohort
study.
Consecutive
ARDS
or
without
confirmed
admitted
an
major
tertiary-care
hospital
from
March-December
2020
included.
A
total
160
positive
for
530
enrolled.
Data
collected
both
bivariate
multivariable
analyses
on
status,
demographics,
morphometrics,
comorbidities,
presenting
symptoms,
general
health
status
(APACHE-II)
admission,
parameters
laboratory
tests
at
within
24
h
pre-intubation.
The
treatment
administered
outcomes
also
recorded.
capture
was
almost
100%.
Results:
Numerous
clinical
differences
detected
between
COVID-19.
Most
notably,
generally
older
heavier,
much
more
frequently
presented
fevers/chills,
dyspnea,
cough,
anosmia/ageusia,
sore
throat
—
had
worse
outcomes.
including
over
two-fold
rate
five-fold
survivors
requiring
prolonged
supplemental
oxygen.
symptom
dyad
fevers
and/or
chills
dyspnea
93.0%
sensitive
63.4%
specific
baseline
APACHE-II
Score
≥
17
mechanical
ventilation
94.4%
70.5%
mortality.
All
37
COVID
score
>
30
died,
survival
among
scores
up
40.
Conclusion:
In
one
the
first
large
contemporary
populations
ARDS,
employing
multi-variable
analysis,
numerous
in
characteristics,
presentation,
detected.
Abbreviations:
-
Acute
Physiologic
Assessment
Chronic
Health
Evaluation
2nd
edition;
PaO2
Partial
Pressure
Oxygen;
SaO2
Arterial
Oxygen
Saturation;
BUN
Blood
Urea
Nitrogen;
ALT
Alanine
Aminotransferase;
AST
Aspartate
LDH
Lactate
Dehydrogenase;
NIPPV
Non-
Invasive
Intermittent
Positive
Ventilation;
HFNC
High-Flow
Nasal
Cannula;
ECMO
Extra-Corporeal
Membrane
Oxygenation
Key
words:
COVID-19;
ARDS;
Clinical
Characteristics;
Treatment;
Outcomes;
Predictors
Citation:
Algethamy
HM,
Aboudeif
MM,
Alhandi
MO,
Majrashi
FY,
Hakami
SH,
Jan
MA,
Kabli
HA,
Alhomrani
MH,
White
KP.
Comparing
critically
ill
COVID-19:
prospective,
analysis
690
patients.
Anaesth.
pain
intensive
care
2023;27(6):652−664;
DOI:
10.35975/apic.v27i6.2355
Received:
March
04,
2023;
Revised:
October
09,
Accepted:
25,
2023
Intensive Care Medicine,
Journal Year:
2024,
Volume and Issue:
50(8), P. 1240 - 1250
Published: June 12, 2024
The
development
of
acute
kidney
injury
(AKI)
after
the
respiratory
distress
syndrome
(ARDS)
reduces
chance
organ
recovery
and
survival.
purpose
this
study
was
to
examine
AKI
rate
attributable
mortality
in
ARDS
patients.
European Respiratory Review,
Journal Year:
2023,
Volume and Issue:
32(168), P. 220245 - 220245
Published: May 3, 2023
Awake
prone
positioning
(APP)
of
patients
with
acute
hypoxaemic
respiratory
failure
gained
considerable
attention
during
the
early
phases
coronavirus
disease
2019
(COVID-19)
pandemic.
Prior
to
pandemic,
reports
APP
were
limited
case
series
in
influenza
and
immunocompromised
patients,
encouraging
results
terms
tolerance
oxygenation
improvement.
Prone
awake
appears
result
many
same
physiological
changes
improving
seen
invasively
ventilated
moderate–severe
distress
syndrome.
A
number
randomised
controlled
studies
published
on
varying
severity
COVID-19
have
reported
apparently
contrasting
outcomes.
However,
there
is
consistent
evidence
that
more
requiring
advanced
support,
who
are
managed
higher
care
environments
can
be
for
several
hours,
benefit
most
from
use.
We
review
basis
by
which
lung
mechanics
gas
exchange
summarise
latest
base
primarily
COVID-19.
examine
key
factors
influence
success
APP,
optimal
target
populations
unknowns
will
shape
future
research.
Annals of Intensive Care,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 25, 2025
Abstract
Background
Acute
kidney
injury
(AKI)
is
common
in
critically
ill
patients
and
associated
with
increased
morbidity
mortality.
Its
complications
often
require
renal
replacement
therapy
(RRT).
Invasive
mechanical
ventilation
(IMV)
infections
are
considered
risk
factors
for
the
occurrence
of
AKI.
The
use
IMV
non-invasive
(NIV)
has
changed
over
course
pandemic.
Concomitant
this
change
treatment
a
reduction
incidences
AKI
RRT
was
observed.
We
aimed
to
investigate
impact
on
initiation
by
comparing
without
COVID-19.
Furthermore,
we
wanted
rates
timing
as
well
outcome
patients,
who
were
treated
RRT.
Results
A
total
8,678
included,
which
555
(12.8%)
COVID-19
554
control
group
In
first
week
ICU
stay
showed
significantly
lower
probability
(day
1:
p
<
0.0001,
day
2:
=
0.021).
However,
after
7
reversed
HR
found.
mechanically
ventilated
higher
entire
stay.
While
non-COVID-19
non-significant
trend,
increased.
median
delay
between
requirement
observed
be
longer
(5
days
[IQR:
2–11]
vs.
2
1–5]).
analysis
restricted
death
requiring
compared
IMV.
Conclusion
demonstrated
that
an
association
given
all
investigated
time
intervals.
Additionally,
during
within
admitted
due
respiratory
disease.
RRT,
patients.
Medicina,
Journal Year:
2025,
Volume and Issue:
61(4), P. 556 - 556
Published: March 21, 2025
Background
and
Objectives:
Eosinophilic
lung
diseases
(ELD)
encompass
disorders
with
an
abnormally
high
number
of
polymorphonuclear
eosinophils
in
the
lungs.
Presentation
severity
can
range
from
low-grade
fever
cough
to
life-threatening
acute
respiratory
distress
syndrome
(ARDS).
Due
rarity
these
conditions,
no
large
sample
studies
have
been
performed
assess
characteristics
patients
pulmonary
eosinophilia.
Materials
Methods:
Patients
admitted
a
diagnosis
eosinophilia
between
years
2016
2020
were
extracted
largest
inpatient
US
database,
Nationwide
Inpatient
Sample
(NIS).
under
age
eighteen
those
diabetic
ketoacidosis
excluded.
Baseline
demographic
medical
comorbidities
evaluated
for
individuals
depending
on
intubation
requirement.
The
primary
outcomes
included
in-hospital
mortality,
intubation,
length
stay
(LOS).
Results:
3784
records
extracted,
among
which
384
required
intubation.
who
had
higher
rates
mortality
(23.9%
vs.
1.2%
p
<
0.0001%)
significantly
more
prolonged
hospital
(19
days
6
0.001)
compared
did
not
need
Factors
associated
intubated
group
increasing
(OR:
1.022,
95%
CI
1.002–1.042),
duration
superior
96
h
2.705,
1.235–5.927),
AKI
2.964,
1.637–5.366).
Conclusions:
Our
findings
suggest
that
ELD
requiring
experience
kidney
injury,
deep
venous
thrombosis,
ARDS.
Pathogens,
Journal Year:
2024,
Volume and Issue:
13(4), P. 325 - 325
Published: April 16, 2024
Background:
Human
kidneys
are
an
important
target
of
SARS-CoV-2
infection,
and
many
renal
abnormalities
have
been
found
in
patients
with
including
proteinuria,
hematuria,
acute
kidney
injury.
Acute
injury
is
now
considered
a
common
complication
COVID-19,
the
epidemiology
AKI
SARS-CoV-2-infected
continues
to
be
controversial.
Aim
Methods:
We
carried
out
narrative
review
evaluate
frequency
risk
factors
for
among
hospitalized
due
latest
surveys
on
this
topic
included.
The
mechanisms
by
which
occurs
COVID-19
also
reviewed.
Results:
Multiple
development
infection
identified;
these
classified
various
groups
(management
background
factors,
others).
targets
indirect
activity,
but
infects
tubular
epithelial
cells
podocytes.
retrieved
24
reports
(n
=
502,593
unique
infection)
incidence
31.8%
(range,
0.5%
56.9%).
Only
minority
2)
studies
had
prospective
design.
that
was
greater
who
underwent
in-hospital
deaths
vs.
those
survived;
summary
estimate
unadjusted
RR
2.63
(95%
CI,
2.37;
2.93)
(random-effects
model).
A
stratified
analysis
showed
where
COVID-19-positive
having
comorbidities
(diabetes
mellitus,
arterial
hypertension,
advanced
age)
high.
relative
(aRR)
ICU
admission
did
not;
pooled
2.64
1.96;
3.56)
according
random-effects
model.
Conclusions:
patients,
some
it.
direct
activity
virus
has
mentioned
pathogenesis
patients.
Further
ongoing
order
identify
underlying
population.
role
survival
another
area
active
investigation.
BMJ Open,
Journal Year:
2025,
Volume and Issue:
15(5), P. e094887 - e094887
Published: May 1, 2025
Objectives
To
compare
the
incidence
and
drivers
of
major
adverse
kidney
events
(MAKEs)
between
COVID-19
non-COVID-19
acute
respiratory
distress
syndrome
(ARDS)
patients,
with
a
focus
on
long-term
outcomes.
Design
Retrospective
cohort
study.
Setting
Single-centre
intensive
care
unit
in
Midlands,
UK.
Participants
708
ARDS
patients
(458
COVID-19,
250
non-COVID-19).
Primary
secondary
outcome
measures
The
primary
was
MAKE
at
365
days
(MAKE-365),
defined
as
new
renal
replacement
therapy
(RRT),
estimated
glomerular
filtration
rate
(eGFR)
<75%
baseline
or
all-cause
mortality.
Secondary
analyses
examined
non-mortality
components.
Results
MAKE-365
significantly
higher
group
compared
(66%
vs
39%,
p<0.001),
primarily
driven
by
increased
RRT
initiation,
followed
mortality
eGFR
decline
(p=0.055).
Independent
predictors
included
lower
elevated
bilirubin
both
groups.
Age
(p<0.001)
diabetes
(p=0.041)
were
additional
cohort,
while
albumin
(p=0.002)
significant
group.
Excluding
mortality,
remained
outcomes
cohort.
Conclusions
Non-COVID-19
face
greater
risk
due
to
requirements
rates.
These
findings
underscore
importance
tailored
interventions
nephrology
follow-up,
particularly
for
reduced
eGFR,
comorbidities
like
hypoalbuminaemia.
Indian Journal of Critical Care Medicine,
Journal Year:
2023,
Volume and Issue:
27(10), P. 724 - 731
Published: Sept. 29, 2023
Background:
Acute
kidney
injury
(AKI)
is
a
heterogeneous
syndrome
with
subphenotypes.Acute
one
of
the
most
common
complications
in
acute
respiratory
distress
(ARDS)
patients,
which
influences
mortality.Material
and
methods:
It
was
single-center
observational
study
on
266
ARDS
patients
invasive
mechanical
ventilation
(IMV)
to
determine
subphenotypes
AKI
associated
ARDS.Subphenotyping
done
based
serum
creatinine
(SCr)
trajectories
from
day
1
5
IMV
into
resolving
(subphenotype
1)
or
non-resolving
2)
AKI.Results:
Out
222
were
included
for
data
analysis.141
(63.51%)
had
AKI.The
incidence
subphenotype
2
among
cohort
78/222
(35.13%).Subphenotype
significantly
more
non-survivors
(87.7%
vs
36.2
%,
p
<
0.001).Subphenotype
an
independent
predictor
mortality
(p
0.001,
adjusted
odds
ratio
8.978,
95%
CI
[2.790-28.89].AKI
higher
median
SCr
than
but
lower
levels
by
3
IMV.The
time
survival
8
days
45
[Log-Rank
(Mantel-Cox)
0.001].The
novel
DRONE
score
(Driving
pressure,
Oxygenation,
Nutritional
Evaluation)
≥
4
predicted
AKI.Conclusion:
The
(non-resolving)
about
35%
(vs
20%
AKI),
it
mortality.The
≥4
can
predict
2.
Highlights:
trajectory-based
(resolving
non-resolving)
determines
patients.Non-resolving
ARDS.The
(driving
oxygenation,
nutritional
evaluation)
within
48
hours
ventilated
patients.
Journal of Anesthesia Analgesia and Critical Care,
Journal Year:
2024,
Volume and Issue:
4(1)
Published: July 6, 2024
Abstract
Background
Lung
perfusion
defects,
mainly
due
to
endothelial
and
coagulation
activation,
are
a
key
contributor
COVID-19
respiratory
failure.
patients
may
also
develop
acute
kidney
injury
(AKI)
because
of
renal
deficit.
We
aimed
explore
AKI-associated
factors
the
independent
prediction
standardized
minute
ventilation
(MV)—a
proxy
alveolar
dead
space—on
AKI
onset
persistence
in
mechanically
ventilated
patients.
Methods
This
is
multicenter
observational
cohort
study.
enrolled
157
requiring
mechanical
intensive
care
unit
(ICU)
admission.
collected
clinical
information,
ventilation,
laboratory
data.
was
defined
by
2012
KDIGO
guidelines
classified
as
transient
or
persistent
according
serum
creatinine
criteria
within
48
h.
Ordered
univariate
multivariate
logistic
regression
analyses
were
employed
identify
variables
associated
with
persistence.
Results
Among
on
47%
developed
AKI:
10%
had
AKI,
37%
AKI.
The
degree
hypoxia
not
differences
severity.
Across
increasing
severity
groups,
despite
similar
levels
paCO
2
,
we
observed
an
increased
MV
MV,
robust
space.
After
adjusting
for
other
covariates,
remained
predictor
development
d
-dimer
higher
Conclusions
In
critically
ill
failure,
wasted
independently
greater
risk
These
hypothesis-generating
findings
suggest
that
derangements
link
pathophysiology
both
our
population.